Bortezomib Hospira 3.5 mg powder for solution for injection

Licence status
Authorised: 22/07/2016
Active substances
Bortezomib
Dosage Form
Powder for solution for injection
Licence number
EU/1/16/1114/001
Licence holder
Pfizer Europe MA EEIG

Product documents

Licence information

ATC code
L01XX Other antineoplastic agents, L01XX32 bortezomib
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
22/07/2016